GLP-1 Drugs Linked To Better Breast Cancer Outcomes
In a new study, breast cancer patients using GLP-1 medications for obesity and/or diabetes had a lower risk of recurrence and death over 10 years of follow-up.
Health News is provided as a service to Wolfe Prescription Center site users by HealthDay. Wolfe Prescription Center nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.